Testing a Personalised Dysautonomia Management Protocol in Patients with Orthostatic Intolerance and a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Long COVID
Journal of Clinical Medicine · 25.03.2026 · 15 (7) · 2510
DOI: 10.3390/jcm15072510 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.03.2026. Verfasst von Julia Barr und 9 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The ME Association, ME Association.
Abstract (Originalsprache)
Background/Objectives: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID (LC) are complex multisystem conditions with significant functional disability. Many patients experience symptoms of orthostatic intolerance, which can be captured in some cases as Orthostatic Hypotension (OH) or Postural orthostatic Tachycardia Syndrome (PoTS) on objective testing. Conservative treatments are recommended for first-line symptom management, but there is a lack of efficacy evidence. This study aims to assess the feasibility of an 8-week clinically supervised, personalised Dysautonomia Management Protocol (DMP) in a cohort of ME/CFS and LC patients with subjective and objective evidence of orthostatic intolerance (dysautonomia).
Methods
ME/CFS and LC patients with objective dysautonomia on the 10 min active Lean Test (LT) were recruited to an 8-week DMP, with interventions introduced cumulatively every two weeks. Interventions included increasing daily fluid intake to 3 litres and salt intake to 10 g, pacing to avoid crashes and calf activation. Baseline and weekly data collection included the LT, Composite Autonomic Symptom Score questionnaire (COMPASS-31) and Yorkshire Rehabilitation Scale (YRS).
Results
Sixteen participants completed the 8-week program, five discontinued during the program, and one was withdrawn following a severe crash. The COMPASS-31 improved by 7.7 points from week 1 to week 8 (p = 0.045), with a medium Cohen’s d effect size of 0.55. For the same period, there was a non-significant (p = 0.16) improvement in the YRS symptom severity score by 2 points. Comparing the final two weeks of the program with the first two weeks, mean heart rate during the LT decreased by 4.8 beats per minute (p = 0.032), with a medium Cohen’s d effect size of 0.44. Adherence to the interventions was highly variable, with none of the patients able to fully employ all four recommendations.
Conclusions
The results suggest that targeted conservative interventions could influence autonomic function and symptom reduction. However, the magnitude of change was limited, and statistical significance might not necessarily relate to a clinically significant improvement in symptoms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.
- Leeds Community Healthcare, Leeds LS11 0DL, UK.
- Department of Rehabilitation Medicine, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK.
- Physical Therapy and Rehabilitation Department, College of Applied Medical Sciences, Majmaah University, Al Majma'ah 11952, Saudi Arabia.
- Leeds and York Partnership Foundation Trust, Leeds LS7 3JX, UK.
- Wrightington, Wigan and Leigh NHS Trust, Wrightington WN1 2NN, UK.
ORCID-Profile: Theshan Dassanayake, Norah Almutairi, Vikki McKeever, Manoj Sivan
Förderung
- The ME Association
- ME Association
Zitieren
APA
Barr, J., Marsden, L., Dassanayake, T., Almutairi, N., McKeever, V., Gaber, T., Tarrant, R., Godfrey, B., Witton, S., & Sivan, M. (2026). Testing a Personalised Dysautonomia Management Protocol in Patients with Orthostatic Intolerance and a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Long COVID. Journal of Clinical Medicine, 15(7), 2510. https://doi.org/10.3390/jcm15072510
Vancouver
Barr J, Marsden L, Dassanayake T, Almutairi N, McKeever V, Gaber T, et al. Testing a Personalised Dysautonomia Management Protocol in Patients with Orthostatic Intolerance and a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Long COVID. Journal of Clinical Medicine. 2026;15(7):2510. doi:10.3390/jcm15072510
BibTeX
@article{Barr2026,
author = {Barr, Julia and Marsden, Lowri and Dassanayake, Theshan and Almutairi, Norah and McKeever, Vikki and Gaber, Tarek and Tarrant, Rachel and Godfrey, Belinda and Witton, Sharon and Sivan, Manoj},
title = {Testing a Personalised Dysautonomia Management Protocol in Patients with Orthostatic Intolerance and a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Long COVID},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2510},
doi = {10.3390/jcm15072510}
}
EUVIMED